Ursodeoxycholic acid for chemoprevention in ulcerative colitis and primary sclerosing cholangitis: a retrospectove cohort study

Ullman, Thomas A; Croog, Victoria; Maratchi, Leon; Jaffe, David; Itzkowitz, Steven H
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS258
Academic Journal
An abstract of the article "Ursodeoxycholic Acid for Chemoprevention in Ulcerative Colitis and Primary Sclerosing Cholangitis: A Retrospectove Cohort Study," by Thomas A. Ullman, Victoria Croog, and Leon Maracthi is presented.


Related Articles

  • Chemoprevention of colorectal cancer in ulcerative colitis. Croog, Victoria J.; Ullman, Thomas A.; Itzkowitz, Steven H. // International Journal of Colorectal Disease;Sep2003, Vol. 18 Issue 5, p392 

    Background. Patients with ulcerative colitis (UC) are at greater risk of developing colorectal cancer (CRC) than the general population. Both duration and extent of UC are important risk factors for CRC, as is the presence of primary sclerosing cholangitis, family history of CRC, and (in some...

  • Azathioprine, Mucosal Healing in Ulcerative Colitis, and the Chemoprevention of Colitic Cancer: A Clinical-Practice-Based Forecast. Actis, Giovanni C.; Pellicano, Rinaldo; David, Ezio; Sapino, Anna // Inflammation & Allergy - Drug Targets;Jan2010, Vol. 9 Issue 1, p6 

    The development of colorectal cancer in ulcerative colitis is a function of disease duration, with the risk approaching 14% at 25 years. Colitic cancer has become an issue in the last decades, as the availability of effective immune suppressors has reduced resort to curative colectomies....

  • The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the ß-catenin signaling pathway. Munding, Johanna; Ziebarth, Wibke; Pox, Christian P.; Ladigan, Svetlana; Reiser, Markus; Hüppe, Dietrich; Brand, Linda; Schmiegel, Wolff; Tannapfel, Andrea; Reinacher-Schick, Anke C. // Carcinogenesis;Mar2012, Vol. 33 Issue 3, p637 

    Surveillance colonoscopy is an important strategy for prevention of colorectal cancer. 5-aminosalicylate (ASA) (mesalazine) is discussed as a chemopreventive agent as it reduces the cancer risk in ulcerative colitis patients. The current study analyses the effect of 5-ASA on Wnt/β-catenin...

  • Colorectal cancer and dysplasia in inflammatory bowel disease. Zisman, Timothy L.; Rubin, David T.; Marshall, John K. // World Journal of Gastroenterology;5/7/2008, Vol. 14 Issue 17, p2662 

    Both ulcerative colitis and Crohn's disease carry an increased risk of developing colorectal cancer. Established risk factors for cancer among patients with inflammatory bowel disease (IBD) include the younger age at diagnosis, greater extent and duration of disease, increased severity of...

  • Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer. Stolfi, Carmine; Simone, Veronica De; Pallone, Francesco; Monteleone, Giovanni // International Journal of Molecular Sciences;Sep2013, Vol. 14 Issue 9, p17972 

    Colorectal cancer (CRC) is the third most common malignant neoplasm worldwide. Although conclusive evidence is still lacking, epidemiologic studies suggest that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) has chemopreventive properties against CRC. Similarly, regular...

  • Will a 5-ASA a Day Keep the Cancer (and Dysplasia) Away? Rubin, David T.; Lashner, Bret A. // American Journal of Gastroenterology;Jun2005, Vol. 100 Issue 6, p1354 

    Prevention strategies for colorectal cancer in chronic ulcerative colitis (UC) are currently based on the identification of neoplasia by surveillance colonoscopy, but there is a great interest in the possibility of primary chemoprevention. 5-aminosalicylic acid (5-ASA) therapy is an attractive...

  • Physicians' Perceptions of Risks and Practices in Venous Thromboembolism Prophylaxis in Inflammatory Bowel Disease. Sam, Justina; Bernstein, Charles; Razik, Roshan; Thanabalan, Reka; Nguyen, Geoffrey // Digestive Diseases & Sciences;Jan2013, Vol. 58 Issue 1, p46 

    Background: Hospitalized inflammatory bowel disease (IBD) patients are at a higher risk of venous thromboembolism (VTE). Aims: We aimed to determine perceptions of VTE risks and self-reported practices regarding VTE prophylaxis in hospitalized IBD patients among American gastroenterologists....

  • Ulcerative colitis.  // Mayo Clinic Health Letter;Dec1995, Vol. 13 Issue 12, p1 

    Focuses on ulcerative colitis. Disease as a chronic inflammation of the colon lining; Use of colonoscopy in diagnosing the disease; Complications of the disease; Management of disease flare-ups; Use of surgery in the treatment of disease; Potential drugs for the disease.

  • Easier ulcer diagnosis. Dunkin, Mary Anne // Arthritis Today;Jan/Feb98, Vol. 12 Issue 1, p18 

    Presents information on easier ulcer diagnosis. Identification of the cause of the ulcer; How it is detected; Details on the process.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics